JOSLYN POND: Open Payments
NPI 1982087375 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 36 payments from 13 companies in 2025. Trend: 2023 $256 · 2024 $417 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $146 |
| Sumitomo Pharma America, Inc. | 5 | $118 |
| Novo Nordisk Inc | 3 | $60 |
| Inspire Medical Systems, Inc. | 2 | $55 |
| Verona Pharma, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| ABBVIE INC. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| PFIZER INC. | 1 | $23 |
Products named: MOUNJARO, GEMTESA, Wegovy, INSPIRE, Ohtuvayre, Kerendia, VOQUEZNA, VRAYLAR.
Industry payments across NE — which companies pay providers there.
